• About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV
Tuesday, January 31, 2023
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos
No Result
View All Result
Citinewsroom - Comprehensive News in Ghana
No Result
View All Result

WAHO selects 5 firms to manufacture vaccines for ECOWAS countries

May 10, 2022
Reading Time: 4 mins read
ShareShareShareShare

The West African Health Organisation (WAHO), an organ of the Economic Community of West African States (ECOWAS), is working with five potential vaccine manufacturers to produce vaccines including COVID-19 vaccines for the sub-region and export to other countries around the world.

Some of the companies have set August and September this year to start building their plants and subsequently start manufacturing vaccines in 2022.

The 5 companies

The selected potential manufacturers are DEK Consortium and Atlantic Life Science from Ghana, Innovative Biotech and Biovaccines of Nigeria and Pasteur Institute in Dakar.

Sponsors

Institutions that have made commitments and sponsoring the local vaccine manufacturers include Bill & Melinda Gates Foundation (BMGF), West African Pharmaceutical Manufacturers Association (WAPMA), United Nations Economic Commission for Africa (UNECA) World Health Organisation (WHO) Africa Regional Office and Mastercard Foundation.

The Director-General of WAHO, Professor Stanley Okolo, announced this in Accra at a high-level meeting to consider efforts being made to boost vaccine manufacturing in the ECOWAS region.

This meeting, which is being held in Accra, is being done in collaboration with the Africa Centre for Disease Control (CDC) and vaccine manufacturers from the sub-region.

Strong collaboration

Prof Okolo said, the objective of the meeting is to build a strong collaboration between these manufactures and not to create competition among them.

Fill-and-finish agreements

He explained that some of the potential manufacturers had signed agreements with global vaccine manufacturers to do fill-and-finish and later manufacture their own vaccines.

He said presently, only one per cent of vaccines used in Africa are produced locally.

Prof Okolo noted that the vision is to achieve a 60% increase by the year 2024, stressing that the continent has all the rudiments and building blocks to make this happen.

ECOWAS boosting medical supplies in the sub-region

He explained that given the urgency in the sub-region and the vulnerability of the ECOWAS’ population to the COVID-19 pandemic and other diseases, the ECOWAS Commission and WAHO under the ECOWAS Authorities of Heads of States and Governments are facilitating efforts to boost local vaccines manufacturing and other medical supplies in the sub-region.

This, he said, cannot be achieved without the needed improved infrastructure and human resource capacity.

According to him, the COVID-19 pandemic had shown that low- and middle-income countries have had to rely mostly on donations of vaccines from rich nations.

Prof Okolo, however, explained that research had shown that building continental and regional manufacturing capabilities will contribute to pandemic preparedness and strengthen the response to feature outbreaks.

Currently, he said West Africa requires some 370 million doses of COVID-19 to meet the 70% vaccination target.

He appealed to the manufacturers to openly share their knowledge and expertise and effectively collaborate with one another to achieve the expected breakthrough in vaccine manufacturing in Africa.

Political will obtained

He said one important aim of WAHO is obtaining the political will and the go-ahead of ECOWAS Council of Heads of States and Governments to bring together manufacturers, partners, external collaborators and regulators to advance the manufacture of COVID-19 vaccines.

“Some of the things we have done on the health side is the harmonisation of the regulations so that you don’t have to go through 15 different countries in order to register a medicine, but you go to a central platform,” he added.

The World Health Organisation (WHO) Regional Director for Africa, Dr Matshidiso Moeti, in a speech read on her behalf, pledged her office’s commitment to support ECOWAS.

“We want to confirm the commitment of WHO regional office for West Africa, in collaboration with WHO headquarters, our great commitment to support member states to strength capacity for local production in the region and support member states,” she disclosed.

Dr Moeti noted that the COVID-19 pandemic laid bare the over-reliance of low- and middle-income countries on donations from rich nations.

Chairman of the Presidential Vaccines Committee, Professor Kwabena Frimpong Boateng, said Ghana was working closely with Rwanda and Senegal in the development of the COVID-19 vaccines, which is expected soon in the country for packaging and distribution for commercial use by 2024.

He gave some highlights of Ghana’s progress regarding its vaccine development efforts, citing the expected completion of the National Vaccines Institute infrastructure by the third quarter of 2022 to coordinate the development and manufacturing of vaccines.

Others include strengthening collaboration between existing research capacity enhancement of the Food and Drugs Authority to attain International Standard Organisation Level Four of its laboratory performance, and the enhancement of human resource capacity base for research, management of manufacturing plants, as well as stakeholder engagements for the effective support of government efforts.

By building continental or regional manufacturing capabilities, WAHO hopes to boost pandemic preparedness and strengthen the response to future outbreaks.

As part of the programme for the two-day meeting, WAHO hopes to find out how manufacturers will identify particular vaccines of interest to produce.

Also up for discussion will be the engagement of contract clinical research organisations (CROs) and technology platform of high yield, high-quality product using the most cost-effective methodologies available, as well as clinical trial centres.

Given the urgency in the region and vulnerability of ECOWAS population to the COVID-19 pandemics and other diseases, the ECOWAS Commission and the West AFRICA Health Organisation under the decision of the ECOWAS Authorities of Heads of States have pledged their support for the establishment of a robust vaccine production capacity in the ECOWAS region

Source: The Finder
ShareTweetSendSend
Previous Post

Banda Islamic School shines best at Bono Girls in ICT event

Next Post

‘I’m the best for the General Secretary job, I deliver results ‘ – John Boadu

Related Posts

News

Ghana stagnates on Corruption Perceptions Index; scores 43 for third time

January 31, 2023
Top Stories

Deadline for debt exchange program moved to February 7 with new terms

January 31, 2023
Top Stories

Managers of Max Mart, Palace Mall, Second Cup Coffee arrested for tax non-compliance

January 31, 2023
Technology

Data Protection Commission to prosecute 300 institutions for data security breaches

January 31, 2023
Top Stories

Korle Bu doctors threaten to withdraw services over 13th Month Salary arrears

January 31, 2023
News

It’s essential we uphold ethics of law profession – Court of Appeal Judge

January 31, 2023
Next Post

'I'm the best for the General Secretary job, I deliver results ' - John Boadu

TOP STORIES

24 cocoa licensed buying companies indebted to COCOBOD

January 31, 2023

Ghana stagnates on Corruption Perceptions Index; scores 43 for third time

January 31, 2023

Deadline for debt exchange program moved to February 7 with new terms

January 31, 2023
Load More
ADVERTISEMENT
Citinewsroom – Comprehensive News in Ghana

CitiNewsroom.com is Ghana's leading news website that delivers high quality innovative, alternative news that challenges the status quo.

Archives

Download App

Download

Download

  • About Us
  • Contact Us
  • Photo Gallery
  • Privacy Policy
  • Terms of Use
  • Citi TV

© 2021 All Rights Reserved Citi Newsroom.

No Result
View All Result
  • Home
  • News
  • Business
  • Sports
  • Showbiz
  • Coronavirus
  • Infographics
  • Livestream
  • Videos

© 2021 All Rights Reserved Citi Newsroom.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT